Jade Biosciences Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Jade Biosciences Inc
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade’s pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
/ 
Frequently asked questions
To buy Jade Biosciences Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Jade Biosciences Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Jade Biosciences Inc is JBIO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Jade Biosciences Inc has its primary listing on NASDAQ (Small cap). You can trade Jade Biosciences Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Jade Biosciences Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Jade Biosciences Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Jade Biosciences Inc.